

HY-16215 · 50 mg
MedChemExpress · Cat: HY-16215
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/mipsagargin.html
Description
Mipsagargin G-202 is a novel thapsigargin-based targeted proagent consisting of a prostate-specific membrane antigen PSMA -specific peptide coupled to an analog of the potent sarcoplasmic/endoplasmic reticulum calcium adenosine triphosphatase SERCA pump inhibitor Thapsigargin HY-13433 . Mipsagargin is activated by PSMA-mediated cleavage of an inert masking peptide. Mipsagargin has the potential for refractory, advanced or metastatic solid tumours research.







